How to model the Economics of Vaccine Manufacturing

This whitepaper describes the development and use of a cost model encompassing capital, labor, materials, consumables, and other costs, which are five key parameters of manufacturing for a variety of vaccine modalities: vaccines which use inactivated and attenuated viruses, protein subunit vaccines, virus-like particles (VLP) vaccines, Viral vector vaccines, and mRNA vaccines.

Want to Increase your pDNA purity and Yields? Optimize Your pDNA Downstream Purification Process

Get a step-by-step overview of the plasmid DNA manufacturing process and the challenges in pDNA downstream purification, for mRNA, plasmid-based DNA Vaccines, and Viral Vector applications.

Curious to learn more on PAT, Raman Spectroscopy, and Chemometrics?

Are you curious about Process Analytical Technologies (PAT), Raman spectroscopy, chemometrics and Raman applications in bioprocessing? Watch this 4 part interview series: PAT and Raman Meet the Experts Interview Series.

Strategies for Ensuring Biomanufacturing Resilience for Biologics

There is consensus among the global health community that long-term collaboration in resilient biomanufacturing capacity and supply chains…

Market Watch & Perspectives on Vaccines Manufacturing in APAC

recently commissioned Economist Intelligence Clearstate, a division of The Economist, to conduct a study on the future of…

What to consider for a modular facility with closed processing

The biopharmaceutical industry trends towards new product classes and smaller batch sizes drives even a greater need for…

Scroll to Top